Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome

Autor: Chung WH, van Dijk EHC, Mohabati D, Dijkman G, Yzer S, de Jong EK, Fauser S, Schlingemann RO, Hoyng CB, Boon CJF

Publikováno v: Clinical Ophthalmology, Vol Volume 11, Pp 63-70 (2016)

Wing H Chung,1 Elon H C van Dijk,1 Danial Mohabati,1 Greet Dijkman,1 Suzanne Yzer,2 Eiko K de Jong,3 Sascha Fauser,4 Reinier O Schlingemann,5–7 Carel B Hoyng,3 Camiel J F Boon1,5 1Department of Ophthalmology, Leiden University Medical Center, Leide

Externí odkaz: https://doaj.org/article/1e23e5d2fb5d4fa6b96cf48ecee69208

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial

Autor: Vader, M.J.C., Schauwvlieghe, A.M., Verbraak, F.D., Dijkman, G., Hooymans, J.M., Los, L.I., Zwinderman, A.H., Peto, T., Hoyng, C.B., Leeuwen, R. Van, Vingerling, J.R., Jong-Hesse, Y. de, Lith-Verhoeven, J.J. van, Dijkgraaf, M.G., Schlingemann, R.O.

Publikováno v: Ophthalmology. Retina, 4(6), 576-587. Elsevier
Ophthalmology Retina, 4, 6, pp. 576-587
Ophthalmology Retina, 4(6), 576-587. Elsevier Inc.
Ophthalmology Retina, 4, 576-587

Contains fulltext : 220891.pdf (Publisher’s version ) (Open Access) PURPOSE: Comparing the efficacy of intravitreal injections of bevacizumab to ranibizumab in the treatment of macular edema (ME) resulting from retinal vein occlusion (RVO). DESIGN:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ed1245a5f77d8dcaa048cdc8a27f35ba
https://doi.org/10.1016/j.oret.2019.12.019

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial

Autor: Vader, MJC, Schauwvlieghe, ASME, Verbraak, FD, Dijkman, G, Hooymans, JM, Los, LI, Zwinderman, AH, Peto, T, Hoyng, CB, van Leeuwen, R, Vingerling, Hans, Moll, AC, van Lith-Verhoeven, JJC, Dijkgraaf, MG, Schlingemann, RO

Publikováno v: Ophthalmology Retina, 4, 777-788
Ophthalmology. Retina, 4(8), 777-788. Elsevier
Vader, M J C, Schauwvlieghe, A S M E, Verbraak, F D, Dijkman, G, Hooymans, J M M, Los, L I, Zwinderman, A H, Peto, T, Hoyng, C B, van Leeuwen, R, Vingerling, J R, Moll, A C, van Lith-Verhoeven, J J C, Dijkgraaf, M G W, Schlingemann, R O & Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group 2020, ' Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME) : The BRDME Study, a Randomized Trial ', Ophthalmology Retina, vol. 4, no. 8, pp. 777-788 . https://doi.org/10.1016/j.oret.2020.02.008
Ophthalmology Retina, 4, 8, pp. 777-788
Ophthalmology Retina, 4(8), 777-788. Elsevier Inc.

Contains fulltext : 225964.pdf (Publisher’s version ) (Open Access) PURPOSE: To generate conclusive evidence regarding the noninferiority of intravitreal bevacizumab compared with ranibizumab in patients with diabetic macular edema (DME). DESIGN: C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::21d84ae21c4574ca9ed25e7a08a51e62
http://hdl.handle.net/2066/225964

Reply

Autor: Dijk, E.H.C. van, Fauser, S., Breukink, M.B., Blanco-Garavito, R., Keunen, J.E.E., Groenewoud, J.M.M., Peters, P.J.H., Dijkman, G., Souied, E.H., Maclaren, R.E., Querques, G., Downes, S.M., Hoyng, C.B., Boon, C.J.F.

Publikováno v: Ophthalmology, 126, e11

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::23a0524538e2747fca7ebbe660f0ac9c
http://hdl.handle.net/2066/203199

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.

Autor: Schauwvlieghe, A. M. E.¹, Dijkman, G.², Hooymans, J. M.³, Verbraak, F. D.^1,4,5, Hoyng, C. B.⁶, Dijkgraaf, M. G. W.⁷, Peto, T.⁸, Vingerling, J. R.^9,10, Schlingemann, R. O.^1,4,11 r.schlingemann@amc.uva.nl

Publikováno v: PLoS ONE. 5/20/2016, Vol. 11 Issue 5, p1-16. 16p.